MedTrace Logo

Evaluation of SkillTalk for Autistic Young Adults

NCT06281171 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2025-05-21

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to evaluate the effectiveness of using a Microskills video training library for young adults, aged 18-28, with autism spectrum disorder (ASD) to enhance their skills in developing and maintaining healthy relationships.

The main questions it aims to answer are:

* Does using SkillTalk increase autistic young adults skills in the communications skills that are demonstrated in the video curriculum (skills: resolve conflict, compromise, give feedback)?
* Does using SkillTalk increase reported confidence and satisfaction in communication and relationship skills?
* Does using SkillTalk increase interpersonal competence?
* Does using SkillTalk increase ability to cope with rejection?
* Does using SkillTalk improve mental health and wellbeing?

Participants will be asked to:

* Take a survey at the beginning of the study, after one month the end of the study, and at 3-month follow up
* Participate in recorded video calls with projects staff, comprised of 2-3 brief roleplay scenarios of relationship skills at the beginning of the study, after one month the end of the study, and at 3-month follow up
* Watch a minimum of 85% of the 60 minutes of video assigned

Conditions

Interventions

OTHER

SkillTalk for Autistic Young Adults

A Microskills video training library on communication skills for autistic young adults.

OTHER

Flyer Library

A collection of existing online resources on relationship skills

Sponsors & Collaborators

  • dfusion Inc

    lead INDUSTRY

Principal Investigators

  • Regina Firpo-Triplett, MPH · dfusion Inc

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06281171 on ClinicalTrials.gov